Global Tuberculosis Testing Market to reach USD 2.6 Billion by 2027 at a CAGR of 5.1%

By Judy J. Beasley Last updated Nov 1, 2022

company logo

Global Tuberculosis Testing Market

Dublin, Oct. 31, 2022 (GLOBE NEWSWIRE) — The “TB Screening – Global Market Trajectory and Analysis” report has been added to from ResearchAndMarkets.com offer.

Global Tuberculosis Testing Market to Reach $2.6 Billion by 2027

Amid the COVID-19 crisis, the global tuberculosis screening market estimated at US$1.8 billion in 2020 is expected to reach a revised size of US$2.6 billion by 2027, with growing at a CAGR of 5.1% over the period 2020-2027. . Culture-based testing, one of the segments analyzed in the report, is expected to register a CAGR of 5.3% and reach US$634.3 million by the end of the analysis period. Given the ongoing post-pandemic recovery, growth of the Chest X-ray segment is readjusted to a revised CAGR of 3.8% for the next 7-year period.

The US market is estimated at $117.7 million, while China is expected to grow at a CAGR of 5.4%

The tuberculosis screening market in the United States is estimated to be worth US$117.7 million in 2020. China, the world’s second largest economy, is expected to reach a projected market size of US$330.1 million by 2027, with a CAGR of 5.4% over the period between 2020 and 2027. Other noteworthy geographic markets include Japan and Canada, which each forecast growth of 3.1% and period 2020-2027. In Europe, Germany is expected to grow around 4.1% CAGR. Led by countries like Australia, India, and South Korea, the Asia-Pacific market is expected to reach US$1.1 billion by 2027.

The Interferon Gamma Release Assay (IGRA) segment will register a CAGR of 6.5%

In the global Interferon-Gamma Release Assay (IGRA) segment, the United States, Canada, Japan, China and Europe will drive the estimated CAGR of 6.5% for this segment. These regional markets representing a combined market size of US$47.8 million in 2020 will reach a projected size of US$69.9 million by the end of the analysis period. China will remain among the fastest growing markets in this group of regional markets. Latin America will grow at a CAGR of 6.2% during the analysis period.

Select contestants (55 total featured)

Abbott Laboratories, Inc.
Akonni Biosystems, Inc.
Alere, Inc.
Becton, Dickinson and company
bioMérieux SA
Cepheid, Inc.
Creative diagnosis
Danaher Corporation
Epistem Ltd.
F. Hoffmann-La Roche AG
Hain Lifescience GmbH
Hologic, Inc.
Lionex GmbH
Oxford Immunotec Ltd.
Qiagen AG
ThermoFisher Scientific, Inc.

Main topics covered:

I. METHODOLOGY

II. ABSTRACT

1. MARKET OVERVIEW

Impact of Covid-19 and a looming global recession
Review of the year 2021 and short-term outlook
COVID-19 unveils progress against tuberculosis and pushes mortality for the first time in a decade
Low funding remains a palpable challenge
Increase in TB deaths amid COVID-19: A wake-up call to boost R&D funding
Efforts to integrate testing for TB and COVID-19
Competition
Competitive Market Presence – Strong/Active/Niche/Trivial for 55 players globally in 2022 (E)
Global Market Overview and Outlook
The Global Tuberculosis Testing Market Exhibits a High Degree of Momentum and Vigor
North America claims dominant revenue share
Culture-Based Testing and Hospitals: Key Contributors to the Tuberculosis Testing Market
Prominent factors influencing the dynamism of the Global Tuberculosis Testing Market
Intense competition drives players to bet on innovations
Recent market activity

2. FOCUS ON CERTAIN PLAYERS

3. MARKET TRENDS AND DRIVERS

Global TB Control Efforts to Drive TB Testing Market
Molecular diagnostic innovations take center stage in TB testing
WHO aims to improve access to rapid molecular tests for the diagnosis of tuberculosis and drug-resistant tuberculosis
WHO Approved Molecular Platforms and Tests
Strengthening technological innovations, TB screening takes a new direction
Tuberculosis screening: the dawn of artificial intelligence technology
Nanodiagnostics poised to witness TB testing market growth
A nanobiosensor for the rapid detection of Mycobacterium Tuberculosis
CRISPR-based biosensing to see significant growth in pediatric TB
Current Limits and Future Directions

4. GLOBAL MARKET OUTLOOK

III. MARKET ANALYSIS

UNITED STATES

CANADA

JAPAN

CHINA

EUROPE

FRANCE

GERMANY

ITALY

SPAIN

RUSSIA

THE REST OF EUROPE

ASIA PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF THE MIDDLE EAST

AFRICA

IV. COMPETITION

For more information on this report, visit https://www.researchandmarkets.com/r/cbngaz

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900